Keywords: british, biotech, gets, boost, s-p, signs, mmpi

British Biotech gets boost as S-P signs MMPI deal worth up to $60 million -

Article | 08 September 1999

After publishing promising data from a Phase III trial of its matrixmetalloproteinase inhibitor marimastat for the treatment of gastric cancer ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Schering Plough

Schering-Plough

Go to company listing